These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 18723960

  • 21. Prevalence and antimicrobial susceptibility of extended-spectrum beta lactamases-producing Escherichia coli and Klebsiella pneumoniae isolated in selected hospitals of Anyigba, Nigeria.
    Mofolorunsho KC, Ocheni HO, Aminu RF, Omatola CA, Olowonibi OO.
    Afr Health Sci; 2021 Jun; 21(2):505-512. PubMed ID: 34795702
    [Abstract] [Full Text] [Related]

  • 22. Detection of Amp C genes encoding for beta-lactamases in Escherichia coli and Klebsiella pneumoniae.
    Shanthi M, Sekar U, Arunagiri K, Sekar B.
    Indian J Med Microbiol; 2012 Jun; 30(3):290-5. PubMed ID: 22885194
    [Abstract] [Full Text] [Related]

  • 23. Bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy.
    Kang CI, Kim SH, Park WB, Lee KD, Kim HB, Kim EC, Oh MD, Choe KW.
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4574-81. PubMed ID: 15561828
    [Abstract] [Full Text] [Related]

  • 24. [Prevalence of extended-spectrum beta-lactamases in nosocomial Escherichia coli and Klebsiella spp. strains isolated from blood cultures].
    Zarakolu P, Metan G, Hasçelik G, Akova M.
    Mikrobiyol Bul; 2007 Oct; 41(4):579-84. PubMed ID: 18173077
    [Abstract] [Full Text] [Related]

  • 25. The prevalence of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae among clinical isolates from a general hospital in Iran.
    Bazzaz BS, Naderinasab M, Mohamadpoor AH, Farshadzadeh Z, Ahmadi S, Yousefi F.
    Acta Microbiol Immunol Hung; 2009 Mar; 56(1):89-99. PubMed ID: 19388560
    [Abstract] [Full Text] [Related]

  • 26. Evaluation of the Clinical and Laboratory Standards Institute phenotypic confirmatory test to detect the presence of extended-spectrum β-lactamases from 4005 Escherichia coli, Klebsiella oxytoca, Klebsiella pneumoniae and Proteus mirabilis isolates.
    Morrissey I, Bouchillon SK, Hackel M, Biedenbach DJ, Hawser S, Hoban D, Badal RE.
    J Med Microbiol; 2014 Apr; 63(Pt 4):556-561. PubMed ID: 24478449
    [Abstract] [Full Text] [Related]

  • 27. [The presence of extended spectrum beta-lactamase, KPC-type carbapenemase and plasmid-mediated AmpC beta-lactamase in E.coli and K.pneumoniae strains isolated from blood cultures].
    Baykal A, Cöplü N, Simşek H, Esen B, Gür D.
    Mikrobiyol Bul; 2012 Apr; 46(2):159-69. PubMed ID: 22639305
    [Abstract] [Full Text] [Related]

  • 28. Phenotypic expression and prevalence of multi drug resistant extended spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae in Karachi, Pakistan.
    Fatima S, Muhammad IN, Khan MN, Jamil S.
    Pak J Pharm Sci; 2018 Jul; 31(4):1379-1384. PubMed ID: 30033423
    [Abstract] [Full Text] [Related]

  • 29. Molecular characteristics of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae causing intra-abdominal infections from 9 tertiary hospitals in China.
    Liao K, Chen Y, Wang M, Guo P, Yang Q, Ni Y, Yu Y, Hu B, Sun Z, Huang W, Wang Y, Wu A, Feng X, Luo Y, Hu Z, Chu Y, Chen S, Cao B, Su J, Gui B, Duan Q, Zhang S, Shao H, Kong H, Xu Y.
    Diagn Microbiol Infect Dis; 2017 Jan; 87(1):45-48. PubMed ID: 27773544
    [Abstract] [Full Text] [Related]

  • 30. Antimicrobial susceptibility of clinical Enterobacteriaceae isolates at the emergency department in a regional hospital: A threat of extended spectrum beta-lactamase-producers among nursing home residents.
    Liu HC, Hung YP, Lin HJ, Liu HC, Lee JC, Wu YH, Li CW, Li MC, Ko WC.
    J Microbiol Immunol Infect; 2016 Aug; 49(4):584-90. PubMed ID: 26692184
    [Abstract] [Full Text] [Related]

  • 31. Ertapenem susceptibility of extended spectrum beta-lactamase-producing organisms.
    Mody RM, Erwin DP, Summers AM, Carrero HA, Selby EB, Ewell AJ, Moran KA.
    Ann Clin Microbiol Antimicrob; 2007 Jun 06; 6():6. PubMed ID: 17553151
    [Abstract] [Full Text] [Related]

  • 32. Antibacterial susceptibility of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
    Bishara J, Livne G, Ashkenazi S, Levy I, Pitlik S, Ofir O, Lev B, Samra Z.
    Isr Med Assoc J; 2005 May 06; 7(5):298-301. PubMed ID: 15909461
    [Abstract] [Full Text] [Related]

  • 33. Effects of phenotype and genotype on methods for detection of extended-spectrum-beta-lactamase-producing clinical isolates of Escherichia coli and Klebsiella pneumoniae in Norway.
    Tofteland S, Haldorsen B, Dahl KH, Simonsen GS, Steinbakk M, Walsh TR, Sundsfjord A, Norwegian ESBL Study Group.
    J Clin Microbiol; 2007 Jan 06; 45(1):199-205. PubMed ID: 17079502
    [Abstract] [Full Text] [Related]

  • 34. High prevalence of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates: A 5-year retrospective study at a Tertiary Hospital in Northern Thailand.
    Siriphap A, Kitti T, Khuekankaew A, Boonlao C, Thephinlap C, Thepmalee C, Suwannasom N, Khoothiam K.
    Front Cell Infect Microbiol; 2022 Jan 06; 12():955774. PubMed ID: 36004324
    [Abstract] [Full Text] [Related]

  • 35. Prevalence of Extended Spectrum Beta-Lactamase Producing Klebsiella Pneumoniae Isolated From Urinary Tract Infected Patients.
    Chaudhary P, Bhandari D, Thapa K, Thapa P, Shrestha D, Chaudhary HK, Shrestha A, Parajuli H, Gupta BP.
    J Nepal Health Res Counc; 2016 May 06; 14(33):111-115. PubMed ID: 27885293
    [Abstract] [Full Text] [Related]

  • 36. Evaluation of the capability of the VITEK 2 system to detect extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates, in particular with the coproduction of AmpC enzymes.
    Chen HM, Wu JJ, Tsai PF, Wann JY, Yan JJ.
    Eur J Clin Microbiol Infect Dis; 2009 Jul 06; 28(7):871-4. PubMed ID: 19214606
    [Abstract] [Full Text] [Related]

  • 37. Prevalence of blaTEM , blaSHV and blaCTX-M genes in clinical isolates of Escherichia coli and Klebsiella pneumoniae from Northeast India.
    Bora A, Hazarika NK, Shukla SK, Prasad KN, Sarma JB, Ahmed G.
    Indian J Pathol Microbiol; 2014 Jul 06; 57(2):249-54. PubMed ID: 24943758
    [Abstract] [Full Text] [Related]

  • 38. In vitro activity of ertapenem and other carbapenems against extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae clinical isolates in a tertiary care center in Turkey.
    Kiremitci A, Dinleyici EC, Erben N, Durmaz G, Yargic ZA, Aybey AD, Usluer G.
    Expert Opin Pharmacother; 2008 Jun 06; 9(9):1441-9. PubMed ID: 18518776
    [Abstract] [Full Text] [Related]

  • 39. Extended-spectrum beta-lactamase-producing phenotype signifies a poor prognosis for patients with cefpodoxime-resistant Escherichia coli or Klebsiella pneumoniae bacteremia.
    Lee CI, Lee NY, Yan JJ, Lee HC, Ko NY, Chang CM, Wu CJ, Chen PL, Wang LR, Ko WC.
    J Microbiol Immunol Infect; 2009 Aug 06; 42(4):303-9. PubMed ID: 19949753
    [Abstract] [Full Text] [Related]

  • 40. Antimicrobial susceptibilities of urinary extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae to fosfomycin and nitrofurantoin in a teaching hospital in Taiwan.
    Liu HY, Lin HC, Lin YC, Yu SH, Wu WH, Lee YJ.
    J Microbiol Immunol Infect; 2011 Oct 06; 44(5):364-8. PubMed ID: 21524974
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.